Please Wait

Applying Filters...

Cefotaxime
CEP/COS
Table View

Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Cefotaxime

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 14 USDMF, 17 CEP/COS, 1 JDMF, 5 EU WC, 7 KDMF, 1 NDC API, 23 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

275 FDF Dossiers, 40 FDA Orange Book, 115 Europe, 2 Canada, 27 South Africa, 91 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 6 News #PharmaBuzz

GLOBAL SALES INFORMATION

54 Regulatory FDF Prices

54 Regulatory FDF Prices

MARKET PLACE

22 APIs, 10 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 4 Others

$ Xls download

Filters

Log in to download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
31/10/2025	ACS DOBFAR SPA	Italy	ACS DOBFAR S.P.A. Tribiano IT	R1-CEP 1998-050 - Rev 03	Cefotaxime sodium, Sterile	2008-02-28	Valid	Chemical		989
31/10/2025	Aurobindo Pharma Limited	India	AUROBINDO PHARMA LIMITED Hyderabad IN	R1-CEP 2005-203 - Rev 01	Cefotaxime sodium, Sterile	2013-06-07	Withdrawn by Holder	Chemical	2014-02-06	989

Contact us
to update this info

Cefotaxime

Cefotaxime

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

41 API Suppliers

14 USDMF

17 CEP/COS

1 JDMF

5 EU WC

7 KDMF

1 NDC API

23 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

275 FDF Dossiers

40 FDA Orange Book

115 Europe

2 Canada

27 South Africa

91 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

54 Regulatory FDF Prices

MARKET PLACE

22 APIs

10 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM

4 Others

Filters

INJECTABLE;INJECTION - EQ 10GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 500MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons